The symptoms and influencing factors of patients with esophageal cancer in postoperative rehabilitation
- VernacularTitle:食管癌患者术后康复期症状及其影响因素的调查研究
- Author:
MIAO Yan
1
,
2
;
XIE Qin
1
,
2
;
LI Yaling
1
,
2
;
LUO Chunyan
1
,
2
;
LENG Xuefeng
1
,
2
;
HAN Yongtao
1
,
2
Author Information
1. Department of Thoracic Surgery, Sichuan Cancer Hospital &
2. Research Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610041, P.R. China
- Publication Type:Journal Article
- Keywords:
Esophageal cancer;
surgery;
rehabilitation;
symptoms
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(01):52-56
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the symptom characteristics and influencing factors in order to provide reference for symptom management of patients with esophageal cancer after operation. Methods A total of 216 esophageal cancer patients, including 180 males and 36 females with an average age of 63.7±8.3 years, who underwent surgical operation in our hospital from March to October 2018 were recruited and investigated with self-designed symptom questionnaire at 1 month after surgery. Results The top five symptoms were acid reflux (48.6%), cough (42.6%), dysphagia (40.7%), hoarseness (12.0%), and diarrhea (11.6%). Women were more prone to acid reflux (OR=2.053), fatigue (OR=1.932), chest pain (OR=3.681), sleep disturbance (OR=2.419), abdominal pain (OR=3.882), nausea (OR=3.014) and vomiting (OR=2.505). Patients over 60 years were more prone to dysphagia (OR=2.274). Patients with lower thoracic esophageal cancer had a higher incidence of dysphagia compared with patients with carcinoma of esophagogastric junction (OR=0.326). Patients who had neoadjuvant chemotherapy were more likely to suffer acid reflux (OR=1.594). Open surgery (OR=3.681) and neoadjuvant radiotherapy (OR=2.495) were the risk factors of chest pain. Conclusion There are many symptoms in patients with esophageal cancer after operation, and the occurrence of symptoms is closely related to gender, age, tumor location, surgical procedure and neoadjuvant chemoradiotherapy.
